Adamas Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ADMS
CUSIP
00548A106
All holders as of
Q3 2021
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q3 65 28.6 M $140 M
2021 Q2 69 28.8 M $152 M
2021 Q1 77 28.9 M $139 M
2020 Q4 70 14.3 M $61.9 M
2020 Q3 65 12.8 M $52.9 M
2020 Q2 65 13.1 M $33.5 M
2020 Q1 75 15.5 M $44.8 M
2019 Q4 87 16.7 M $63.2 M
2019 Q3 91 14.5 M $74.2 M
2019 Q2 89 22.6 M $140 M
2019 Q1 103 21.1 M $150 M
2018 Q4 107 24.5 M $209 M
2018 Q3 137 26.2 M $522 M
2018 Q2 137 26.3 M $678 M
2018 Q1 127 25.4 M $606 M
2017 Q4 124 20.7 M $702 M
2017 Q3 107 18.5 M $391 M
2017 Q2 80 15.8 M $276 M
2017 Q1 74 15.9 M $279 M
2016 Q4 81 16.2 M $274 M
2016 Q3 83 16.7 M $274 M
2016 Q2 86 16.1 M $244 M
2016 Q1 85 14.3 M $209 M
2015 Q4 96 11.3 M $320 M
2015 Q3 83 10.5 M $180 M
2015 Q2 89 10.3 M $269 M
2015 Q1 63 8.64 M $151 M
2014 Q4 52 11.3 M $196 M
2014 Q3 45 3.43 M $63.8 M
2014 Q2 38 3.12 M $57.0 M